Wednesday, June 03, 2020 7:23:25 AM
HEALTHCAREJUNE 2, 2020 / 4:08 PM / UPDATED 13 HOURS AGO
BRIEF-Eight Corporation Limited Reports 23.8% Stake In Volitionrx Ltd As Of May 29
1 MIN READ
June 2 (Reuters) - VolitionRX Ltd:
* EIGHT CORPORATION LIMITED REPORTS 23.8% STAKE IN VOLITIONRX LTD AS OF MAY 29 - SEC FILING
* EIGHT CORPORATION LTD-ON MAY 29, CONTACTED VOLITIONRX’S BOARD TO REQUEST EXPANSION OF BOARD AS WELL AS APPOINTMENT OF 3 DIRECTORS SELECTED BY THEM
* EIGHT CORPORATION LTD - REQUESTED VOLITIONRX’S BOARD FORM A COMMITTEE TO EVALUATE, AMONG OTHER THINGS, BUSINESS STRATEGY AND SUCCESSION PLANS
* EIGHT CORPORATION LTD - HAD PREVIOUSLY REPORTED 29.2% STAKE IN VOLITIONRX AS OF MAY 7 Source text: (bit.ly/2Y8YnEv) Further company coverage:
Our Standards:The Thomson Reuters Trust Principles.
https://uk.reuters.com/article/brief-eight-corporation-limited-reports/brief-eight-corporation-limited-reports-238-stake-in-volitionrx-ltd-as-of-may-29-idUKFWN2DF0O6
Recent VNRX News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 08:30:19 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:13:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 08:12:43 PM
- VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update • PR Newswire (US) • 03/31/2026 08:05:00 PM
- VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium • PR Newswire (US) • 03/31/2026 12:16:00 PM
- Volition Announces Mayo Clinic Study Demonstrates Nu.Q® Concentrations are Elevated in Trauma Patients • PR Newswire (US) • 03/30/2026 12:13:00 PM
- Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference • PR Newswire (US) • 03/26/2026 12:17:00 PM
- VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update • PR Newswire (US) • 03/25/2026 08:12:00 PM
- Volition Announces Detection of Over 95% of Early-Stage Cancers • PR Newswire (US) • 03/25/2026 12:17:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:30:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2026 08:30:11 PM
- Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA • PR Newswire (US) • 03/18/2026 12:17:00 PM
- Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems • PR Newswire (US) • 03/06/2026 01:10:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:32:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:32:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:32:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:31:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:31:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:30:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:30:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:30:29 PM
- VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution • PR Newswire (US) • 02/25/2026 01:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 10:15:32 PM
